Brachyury-targeted immunotherapy combined with gemcitabine against head and neck cancer.
Yamaki H, Kono M, Wakisaka R, Komatsuda H, Kumai T, Hayashi R, Sato R, Nagato T, Ohkuri T, Kosaka A, Ohara K, Kishibe K, Takahara M, Hayashi T, Kobayashi H, Katada A.
Yamaki H, et al. Among authors: kono m.
Cancer Immunol Immunother. 2023 Aug;72(8):2799-2812. doi: 10.1007/s00262-023-03460-0. Epub 2023 May 12.
Cancer Immunol Immunother. 2023.
PMID: 37173455
Free PMC article.